​

Bellevue Life Sciences Acquisition Stock (NASDAQ:BLAC)

RevenueOwnershipFinancialsChart

Previous Close

$6.73

52W Range

$3.01 - $13.40

50D Avg

$10.74

200D Avg

$10.87

Market Cap

$6.98M

Avg Vol (3M)

$15.26K

Beta

0.53

Div Yield

-

BLAC Company Profile

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Mar 21, 2023

Website

BLAC Performance

BLAC Financial Summary

Dec 25Dec 24Dec 23
Revenue$2.91M--
Operating Income$-18.34M$-3.52M$-1.83M
Net Income$-28.89M$-2.41M$403.78K
EBITDA$-18.34M$-3.52M$3.72M
Basic EPS-$-0.54$0.07
Diluted EPS-$-0.54$0.07

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
BNIXBannix Acquisition Corp.
JVSAJV SPAC Acquisition Corp. Class A Ordinary Share
RFACRF Acquisition Corp.